News / 

Support for arming Syrian rebels...Heroes honored...Drugmaker sued

Save Story

Estimated read time: 2-3 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — It appears lawmakers favor arming and beefing up moderate Syrian rebels in an effort to take on the group Islamic State. The Obama administration favors aid for credible local ground forces to take on the group in Iraq and Syria. A vote could come as an amendment to a spending bill Congress must pass to keep the government open until mid-December.

WASHINGTON (AP) — Senior Obama administration officials say Syria's missile defense system would be smashed if it would retaliate against American warplanes going after Islamic State targets. President Barack Obama has authorized airstrikes inside Syria to go after the group. However, no strikes in Syria have been carried out so far.

WASHINGTON (AP) — President Barack Obama has presented a Medal of Honor to Army Command Sgt. Maj. Bennie G. Adkins for heroics in Vietnam. Officials say Adkins fought in close combat against enemy forces for 38 hours. The same medal was awarded posthumously to Army Spec. Donald Sloat, who used his body to shield fellow soldiers from a grenade blast.

BLOOMING GROVE, Pa. (AP) — Authorities believe the gunman who ambushed two Pennsylvania State Police troopers, killing one of them, might have had formal firearms training in the military or law enforcement. He apparently used a rifle to open fire outside barracks in Blooming Grove. It's hoped the release of the profile will lead to the arrest of the shooter.

ALBANY, N.Y. (AP) — New York's attorney general is taking Ireland-based drugmaker Actavis to federal court to stop it from discontinuing its widely used Namenda, which is used to treat Alzheimer's patients. Attorney General Eric Schneiderman argues that Actavis is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent News stories

The Associated Press


    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the Trending 5.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast